Therapeutical Practice - Page 3

TOXINA BOTULINICĂ ÎN PRACTICA TERAPEUTICĂ

December 1, 1999
Delia Cinteză *, Maria Cristina Constantinescu *** Dr. Delia Cinteză, asistent universitar, Catedra de Recuperare Medicală și Balneofizioterapie** Dr. Maria Cristina Constantinescu, asistent universitar, Catedra de Farmacologie – Facultatea de Medicină, U.M.F. “Carol Davila”, București Abstract Botulinum toxin A exerts its paralytic action within

THE ROLE OF CITOMETRY AND CITOGENETICS IN THE MANAGEMENT OF MYELODYSPLASTIC SYNDROMES

March 1, 2018
Nicorescu Iuliana-Maria 1, Vlădăreanu Ana-Maria 2, Georgescu Daniela 3, Mihai Felicia 21 NeoLife Clinics, Bucharest2 Universitary Emengency Hospital, Bucharest3 Colentina Clinical Hospital Abstract Myelodysplastic syndromes represent clonal diseases of hematopoietic stem cells that occur predominantly in elderly people, but myelodysplastic syndromes can affect younger patients as well. To achieve the highest success rate of treatment
1 2 3 4 5 30